HQL vs HSBC: Which Is the Better Dividend Stock?
As of September 2026, HQL (Abrdn Life Sciences Investors) screens as the stronger dividend stock, winning 4 of 7 head-to-head metrics. HQL offers the higher yield at 11.62%, HSBC has the higher dividend-safety score, and HQL trades at the larger discount to fair value (+223%).
| Metric | HQL | HSBC |
|---|---|---|
| Forward yield | 11.62% | 3.72% |
| Annual dividend | $2.24 | $3.75 |
| Payout ratio | 29% | 54% |
| Years of growth | 0 yr | 0 yr |
| 5-yr dividend growth | 7.8% | -13.8% |
| 5-yr total return | -5% | 303% |
| Dividend safety score | 63 (C) | 72 (B) |
| Fair value estimate | $63.78 | $136.26 |
| Upside to fair value | +223% | +29% |
| Frequency | quarterly | quarterly |
| Market cap | $595.1M | $352.0B |
| P/E ratio | 2.9 | 14.4 |
Higher yield
HQL
11.62%
Safer dividend
HSBC
Grade B
Faster growth
HQL
7.8%
Better value
HQL
+223% upside
HQL vs HSBC — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.